Contact Levi & Korsinsky by July 7, 2025 Deadline to Join Class Action Against West Pharmaceutical Services, Inc. (WST)

Core Viewpoint - A class action securities lawsuit has been filed against West Pharmaceutical Services, Inc. for alleged securities fraud affecting investors between February 16, 2023, and February 12, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit aims to recover losses for investors who were adversely affected by alleged securities fraud during the specified period [2]. - The complaint alleges that West Pharmaceutical Services made false statements regarding customer demand and operational performance, particularly concerning its high-margin HVP portfolio and the SmartDose device [3]. - Specific allegations include that West was experiencing significant destocking in its HVP portfolio, contrary to claims of strong visibility into customer demand [3]. - The SmartDose device was described as dilutive to profit margins due to operational inefficiencies, contradicting its positioning as a high-margin growth product [3]. - The lawsuit also highlights potential risks of costly restructuring activities, including the exit from continuous glucose monitoring contracts with longstanding customers [3]. Group 2: Next Steps for Investors - Investors who suffered losses during the relevant timeframe have until July 7, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [4]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [5]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [5].